GlaxoSmithKline ($GSK) is in the process of reviewing regulatory results from a June inspection that found that 10 areas of its Ste. Foy, Quebec vaccine manufacturing ...
GSK today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration for FLULAVAL® QUADRIVALENT (Influenza Vaccine). This vaccine is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results